SuperworthCadrenal Therapeutics market cap CVKD
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $3.4M
- Highest close in our data
- $36.4M
- Mar 2025
Cadrenal Therapeutics is worth $3.4M at the close on Oct 23, 2026, at $0.96 a share.
That is down 88% over the last year.
Its highest close in our data was $36.4M in Mar 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.4M | $3.2M | $17.6M | −78% |
| 2025 | $15.4M | $14.8M | $36.4M | −43% |
| 2024 | $26.8M | $6.4M | $29.4M | +178% |
| 2023 | $9.6M | $5.5M | $19.3M | n/a |
Against its peers
Companies in Healthcare nearest Cadrenal Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CVKDCadrenal Therapeutics | $3.4M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| BCGBinah Capital | $18.2M |
| VIPVulcan Infrastructure & Power | $19.6M |
| MXCMexco Energy | $20.5M |
| CKXCKX Lands | $21.5M |
| MSGMMotorsport Games | $22.5M |
| ATCHAtlasClear | $24M |
| Peer median | $18.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Cadrenal Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.